Mapi Pharma receives US patent for multiple sclerosis treatm

A board to discuss the Multiple Sclerosis modifying drug Copaxone
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Mapi Pharma receives US patent for multiple sclerosis treatm

Post by MSUK »

Mapi Pharma, developer of complex bulk Active Pharmaceutical Ingredients (APIs), has been granted a US patent for a long acting depot formulation of glatiramer acetate, which is under the development as a once-a-month treatment for Multiple Sclerosis (MS).... Read More - http://www.ms-uk.org/index.cfm/copaxone
MS-UK - http://www.ms-uk.org/
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Copaxone”